Acebilustat (CAS 943764-99-6), also known as ZK322, is a novel, oral, potent and selective leukotriene A4 hydrolase inhibitor that is a promising new once-daily oral antiinflammatory drug in development for treatment of cystic fibrosis (CF) and other diseases.
This report contains market size and forecasts of Acebilustat in global, including the following market information:
Global Acebilustat Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Acebilustat Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Acebilustat companies in 2021 (%)
The global Acebilustat market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acebilustat include BioVision, Toronto Research Chemicals, AbMole, Adooq Bioscience, CSNpharm, BOC Sciences, InvivoChem, TargetMol and Taiclone, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acebilustat manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acebilustat Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Acebilustat Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Acebilustat Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Acebilustat Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Acebilustat Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Acebilustat Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acebilustat revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Acebilustat revenues share in global market, 2021 (%)
Key companies Acebilustat sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Acebilustat sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioVision
Toronto Research Chemicals
AbMole
Adooq Bioscience
CSNpharm
BOC Sciences
InvivoChem
TargetMol
Taiclone
Wuhan Sun-shine Bio-technology
MedKoo Biosciences
AA Blocks